Kraig Biocraft Laboratories Inc (KBLB)

[midas716]

Little or no revenue... yet. If it's true and KBLB can produce a higher quality product at 1% of the cost of their competitors, that is seriously disruptive to the market.

The market is estimated to be 3b to 5b. If KBLB can, in the future, capture just 1b of the market, where does that put the share price? Over $1.00. A company does not have to produce revenue for a stock price to go up. Just look at any BioTech stock. Some trading at $10 dollars a share and still producing Q after Q of losses yet the price keeps going up. They buy on expectation of future revenue. Especially revenue from a product that has the potential to disrupt a current market segment. Too me it looks like Kraig is now ready to ramp up production of a product that can be produced much cheaper than the current market segment can produce it at.